Key result
Transcatheter tricuspid valve replacement and repair treat severe tricuspid regurgitation, but it remains unclear whether replacement delivers more consistent early clinical improvement.
Comparative analysis reveals early clinical outcomes of tricuspid replacement versus repair in severe tricuspid regurgitation, highlighting therapy selection for high surgical risk cases.
Transcatheter tricuspid valve replacement (TTVR) and repair (T-TEER) have emerged as important treatment options for severe tricuspid regurgitation in patients with high surgical risk. Yet it remains unclear whether valve replacement delivers more consistent early clinical improvement than repair.
No takes yet. Share an insight, caveat, or question.
Beshara et al. (2026) studied this question. Transcatheter tricuspid valve replacement and repair treat severe tricuspid regurgitation, but it remains unclear whether replacement delivers more consistent early clinical improvement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: